Symbol="PRTK"
AssetType="Common Stock"
Name="Paratek Pharmaceuticals Inc"
Description="Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of life-saving therapies for life-threatening diseases or other threats to public health for civil, government and military use. The company is headquartered in Boston, Massachusetts."
CIK="1178711"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="75 PARK PLAZA, 4TH FLOOR, BOSTON, MA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="125448000"
EBITDA="-47908000"
PERatio="None"
PEGRatio="-0.02"
BookValue="-3.3"
DividendPerShare="0"
DividendYield="0"
EPS="-1.16"
RevenuePerShareTTM="2.998"
ProfitMargin="-0.395"
OperatingMarginTTM="-0.29"
ReturnOnAssetsTTM="-0.188"
ReturnOnEquityTTM="0"
RevenueTTM="166643000"
GrossProfitTTM="99389000"
DilutedEPSTTM="-1.16"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0.256"
AnalystTargetPrice="3.1"
TrailingPE="-"
ForwardPE="1.721"
PriceToSalesRatioTTM="0.856"
PriceToBookRatio="-"
EVToRevenue="2.868"
EVToEBITDA="-4.426"
Beta="1.709"
num_52WeekHigh="3.65"
num_52WeekLow="1.29"
num_50DayMovingAverage="2.063"
num_200DayMovingAverage="2.178"
SharesOutstanding="57282000"
DividendDate="2014-10-29"
ExDividendDate="2014-10-31"
symbol="PRTK"
open="2.18"
high="2.19"
low="2.17"
price="2.18"
volume="202177.00"
latest_trading_day="2023-07-26"
previous_close="2.18"
change="0.00"
change_percent="0.0000%"
aroon_positive_momentum_days="62"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="62"
Volume_recent_avg="927809"
Change_recent_avg="0.01"
Delta_recent_avg="0.13"
Variance_recent_avg="0.06"
Change_ratio_recent_avg="-0.3"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="62"
Aroon_momentum_negative="38"
image_negative_thumbnail_id_1="1154"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0188.jpeg"
image_negative_thumbnail_id_2="1122"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0155.jpeg"
image_neutral_thumbnail_id_1="525"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0074.jpeg"
image_neutral_thumbnail_id_2="569"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0030.jpeg"
image_positive_thumbnail_id_1="974"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0136.jpeg"
image_positive_thumbnail_id_2="976"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0138.jpeg"
image_professor_thumbnail_id_1="1201"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0035.jpeg"
image_professor_thumbnail_id_2="1180"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0014.jpeg"
